JPS5151590A - - Google Patents

Info

Publication number
JPS5151590A
JPS5151590A JP50104830A JP10483075A JPS5151590A JP S5151590 A JPS5151590 A JP S5151590A JP 50104830 A JP50104830 A JP 50104830A JP 10483075 A JP10483075 A JP 10483075A JP S5151590 A JPS5151590 A JP S5151590A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP50104830A
Other versions
JPS5910798B2 (ja
Inventor
Howaito Richaado
Ranshini Giankaruro
Antonini Piero
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruppo Lepetit SpA
Original Assignee
Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit SpA filed Critical Lepetit SpA
Publication of JPS5151590A publication Critical patent/JPS5151590A/ja
Publication of JPS5910798B2 publication Critical patent/JPS5910798B2/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/872—Nocardia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP50104830A 1974-08-30 1975-08-29 新しいリフアマイシン類の製造方法 Expired JPS5910798B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3791374A GB1470426A (en) 1974-08-30 1974-08-30 Rifamycins
GB3791374 1974-08-30

Publications (2)

Publication Number Publication Date
JPS5151590A true JPS5151590A (ja) 1976-05-07
JPS5910798B2 JPS5910798B2 (ja) 1984-03-12

Family

ID=10399894

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50104830A Expired JPS5910798B2 (ja) 1974-08-30 1975-08-29 新しいリフアマイシン類の製造方法

Country Status (30)

Country Link
US (2) US4042683A (ja)
JP (1) JPS5910798B2 (ja)
AR (1) AR206232A1 (ja)
AT (1) AT341083B (ja)
BE (1) BE832921A (ja)
CA (1) CA1054959A (ja)
CH (1) CH627784A5 (ja)
CS (1) CS188235B2 (ja)
DD (1) DD119818A5 (ja)
DE (1) DE2537902C2 (ja)
DK (1) DK137866B (ja)
ES (1) ES440560A1 (ja)
FI (1) FI54327C (ja)
FR (1) FR2282878A1 (ja)
GB (1) GB1470426A (ja)
HU (1) HU173751B (ja)
IE (1) IE42605B1 (ja)
IL (1) IL47897A (ja)
IN (1) IN140843B (ja)
LU (1) LU73270A1 (ja)
NL (1) NL162429C (ja)
NO (1) NO142446C (ja)
NZ (1) NZ178519A (ja)
PH (1) PH13481A (ja)
PL (1) PL97788B1 (ja)
RO (1) RO68712A (ja)
SE (1) SE431100B (ja)
SU (1) SU578014A3 (ja)
YU (1) YU39744B (ja)
ZA (1) ZA754951B (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012524060A (ja) * 2009-04-20 2012-10-11 アルファ ワッセルマン ソシエタ ペル アチオニ リファマイシン誘導体

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1470426A (en) * 1974-08-30 1977-04-14 Lepetit Spa Rifamycins
JPS52111502A (en) * 1976-03-16 1977-09-19 Lepetit Spa Novel liphamycin
GB1523198A (en) * 1976-05-28 1978-08-31 Lepetit Spa Thiazolo-rifamycin derivatives
GB1523199A (en) * 1976-05-28 1978-08-31 Lepetit Spa Rifamycin sv derivatives
GB1576886A (en) * 1977-04-20 1980-10-15 Lepetit Spa Rifamycin derivatives
IT1111173B (it) * 1978-04-27 1986-01-13 Lepetit Spa Derivati rifamicinici
US4298692A (en) * 1979-01-25 1981-11-03 Ciba-Geigy Corporation Fermentation process for producing a rifamycin derivative
GB8531887D0 (en) * 1985-12-30 1986-02-05 Lepetit Spa Rifamycin sv derivatives
EP0497125B1 (en) * 1991-01-28 1998-12-09 GRUPPO LEPETIT S.p.A. New process for preparing 2'-(diethylamino)rifamycin P (P/DEA)
US5494178A (en) * 1994-07-25 1996-02-27 Alu Inc. Display and decorative fixture apparatus
DK1698630T3 (da) 2005-03-03 2014-12-08 Alfa Wassermann Spa Nye polymorfe former af rifaximin, fremgangsmåde for deres fremstilling og anvendelse deraf i de medicinske præparater
EP2694085A4 (en) * 2011-04-01 2015-02-11 Univ Northeastern METHODS OF ERADICATING POPULATIONS OF BACTERIAL CELLS
ITBO20120368A1 (it) 2012-07-06 2014-01-07 Alfa Wassermann Spa Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1470426A (en) * 1974-08-30 1977-04-14 Lepetit Spa Rifamycins

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012524060A (ja) * 2009-04-20 2012-10-11 アルファ ワッセルマン ソシエタ ペル アチオニ リファマイシン誘導体

Also Published As

Publication number Publication date
NO752973L (ja) 1976-03-02
AT341083B (de) 1978-01-25
NL162429C (nl) 1980-05-16
FI54327B (fi) 1978-07-31
NL7509998A (nl) 1976-03-02
ATA639275A (de) 1977-05-15
GB1470426A (en) 1977-04-14
SU578014A3 (ru) 1977-10-25
AU8392675A (en) 1977-02-17
HU173751B (hu) 1979-08-28
IE42605L (en) 1976-02-29
IL47897A (en) 1978-03-10
DD119818A5 (ja) 1976-05-12
SE7509571L (sv) 1976-03-01
NZ178519A (en) 1978-06-02
PH13481A (en) 1980-05-19
PL97788B1 (pl) 1978-03-30
US4263404A (en) 1981-04-21
NL162429B (nl) 1979-12-17
DK137866C (ja) 1978-10-23
DE2537902C2 (de) 1982-09-02
US4042683A (en) 1977-08-16
DE2537902A1 (de) 1976-03-18
ES440560A1 (es) 1977-05-16
AR206232A1 (es) 1976-07-07
IL47897A0 (en) 1975-11-25
IN140843B (ja) 1976-12-25
DK137866B (da) 1978-05-22
FR2282878B1 (ja) 1980-05-16
DK379075A (ja) 1976-03-01
IE42605B1 (en) 1980-09-10
ZA754951B (en) 1976-12-29
YU39744B (en) 1985-04-30
FI54327C (fi) 1978-11-10
NO142446B (no) 1980-05-12
FI752417A (ja) 1976-03-01
BE832921A (fr) 1975-12-16
SE431100B (sv) 1984-01-16
CS188235B2 (en) 1979-02-28
NO142446C (no) 1980-08-20
CA1054959A (en) 1979-05-22
LU73270A1 (ja) 1976-04-13
RO68712A (ro) 1982-09-09
JPS5910798B2 (ja) 1984-03-12
YU207475A (en) 1982-05-31
FR2282878A1 (fr) 1976-03-26
CH627784A5 (fr) 1982-01-29

Similar Documents

Publication Publication Date Title
NO752973L (ja)
AU495844B2 (ja)
AU7474374A (ja)
CH583017A5 (ja)
BG27047A4 (ja)
AU480170A (ja)
BG19607A1 (ja)
BG20018A1 (ja)
BG20186A1 (ja)
BG20662A1 (ja)
BG20665A1 (ja)
BG20670A1 (ja)
BG20724A1 (ja)
BG20849A1 (ja)
BG21661A1 (ja)
BG21791A1 (ja)
BG22387A3 (ja)
BG22667A1 (ja)
BG26192A3 (ja)
BG26358A3 (ja)
BG26402A3 (ja)
CH582892A5 (ja)
BG27089A3 (ja)
CH1637174A4 (ja)
CH352875A4 (ja)